David P. Southwell
Net Worth
Last updated:
What is David P. Southwell net worth?
The estimated net worth of Mr. David P. Southwell is at least $3,272,234 as of 18 May 2022. He owns shares worth $271,274 as insider and has received compensation worth at least $3,000,960 in TScan Therapeutics, Inc..
What is the salary of David P. Southwell?
Mr. David P. Southwell salary is $750,240 per year as Pres, Chief Executive Officer & Director in TScan Therapeutics, Inc..
How old is David P. Southwell?
Mr. David P. Southwell is 64 years old, born in 1961.
What stocks does David P. Southwell currently own?
As insider, Mr. David P. Southwell owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| TScan Therapeutics, Inc. (TCRX) | Pres, Chief Executive Officer & Director | 161,569 | $1.68 | $271,274 |
What does TScan Therapeutics, Inc. do?
TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation; and TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204 for the treatment of solid tumors. The company is also developing vaccines for infectious diseases, such as SARS-CoV-2. It has a collaboration and license agreement with Novartis Institutes for BioMedical Research, Inc., to identify novel cancer antigens from the T cells of patients with a certain specific type of cancer. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
David P. Southwell insider trading
TScan Therapeutics, Inc.
TScan Therapeutics key executives
TScan Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Gavin MacBeath (55) Chief Scientific Officer
- Mr. David P. Southwell (64) Pres, Chief Executive Officer & Director